Jeorg Rosenberg

Title: Jeorg Rosenberg: Innovator in Pharmaceutical Dosage Forms

Introduction

Jeorg Rosenberg is a notable inventor based in Ellerstadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage forms that enhance oral bioavailability for HIV protease inhibitors.

Latest Patents

Rosenberg holds a patent for a solid pharmaceutical dosage form that provides improved oral bioavailability for inhibitors of HIV protease. This innovative dosage form comprises a solid dispersion of at least one HIV protease inhibitor, a pharmaceutically acceptable water-soluble polymer, and a surfactant. The water-soluble polymer has a glass transition temperature (Tg) of at least about 50°C, while the surfactant has an HLB value ranging from about 4 to about 10.

Career Highlights

Jeorg Rosenberg is currently associated with AbbVie Inc., where he continues to work on advancing pharmaceutical technologies. His expertise in solid dosage forms has positioned him as a key player in the pharmaceutical industry.

Collaborations

Rosenberg has collaborated with esteemed colleagues such as Ulrich Reinhold and Bernd Liepold, contributing to the advancement of innovative pharmaceutical solutions.

Conclusion

Jeorg Rosenberg's work in developing solid pharmaceutical dosage forms has made a significant impact on the treatment of HIV. His innovative approach and collaboration with other experts in the field highlight his commitment to improving healthcare solutions.